Formulary Insights
Formulary Insights is a purpose-built pharmaceutical-services platform that conducts market access research to help biopharma manufacturers and investors navigate the complex US market access landscape. Powered by Petauri™, it offers broader expertise in global market access, health systems, medical affairs, HEOR, patient services, and data analytics. The company emphasizes delivering cutting-edge insights, agile research, and actionable market access strategies to optimize patient access to life-changing care.
Industries
Nr. of Employees
small (1-50)
Formulary Insights
Indianapolis, Indiana, United States, North America
Products
Capabilities overview (PDF)
Summary document describing market access research approaches, payer panel capabilities, and rapid-study offerings.
Capabilities overview (PDF)
Summary document describing market access research approaches, payer panel capabilities, and rapid-study offerings.
Services
Conduct targeted primary research with payer and health-system decision makers to inform market access strategies.
Pre-prepared studies deployable on short notice under a single statement of work to deliver insights in weeks.
Access to and facilitation of panels composed of active payer decision makers to provide confidential, practical perspectives on coverage and reimbursement.
Iterative research projects combining in-depth interviews and digital modalities to refine hypotheses and recommendations rapidly.
Model formulary placement, utilization impacts, and utilization-management strategies to support payer negotiations and benefit design.
Design and evaluate rebate approaches, rebates negotiation support, and value-based contracting options.
Conduct targeted primary research with payer and health-system decision makers to inform market access strategies.
Pre-prepared studies deployable on short notice under a single statement of work to deliver insights in weeks.
Access to and facilitation of panels composed of active payer decision makers to provide confidential, practical perspectives on coverage and reimbursement.
Iterative research projects combining in-depth interviews and digital modalities to refine hypotheses and recommendations rapidly.
Model formulary placement, utilization impacts, and utilization-management strategies to support payer negotiations and benefit design.
Design and evaluate rebate approaches, rebates negotiation support, and value-based contracting options.
Expertise Areas
- Market access research
- Payer strategy and contracting
- Formulary and reimbursement strategy
- Launch planning and BD&L support
Key Technologies
- Primary market research
- Panel-based qualitative research
- Hybrid interview methods (in-depth + digital)
- Agile iterative research methodology
News & Updates
The high-stakes nature of cancer care, coupled with rapid scientific advancements and increasing payer and regulatory pressures, demands a specialized approach beyond traditional market access strategies.
Market access is about aligning internal strategies with external realities that often change without warning and at a high frequency.
The healthcare ecosystem has undergone a profound transformation, with major insurers now controlling provider networks and pharmacy benefit managers.
Biopharma business development and licensing executives operate in a unique arena, enjoying a privileged view of future pipeline plans while making high-stakes decisions.
The growing importance of Integrated Delivery Networks (IDNs) and health systems exemplifies how the healthcare landscape is rapidly changing.
US payers reject 69% of prescriptions during the first year of FDA approval, highlighting the need for strategic payer engagement.
The high-stakes nature of cancer care, coupled with rapid scientific advancements and increasing payer and regulatory pressures, demands a specialized approach beyond traditional market access strategies.
Market access is about aligning internal strategies with external realities that often change without warning and at a high frequency.
The healthcare ecosystem has undergone a profound transformation, with major insurers now controlling provider networks and pharmacy benefit managers.
Biopharma business development and licensing executives operate in a unique arena, enjoying a privileged view of future pipeline plans while making high-stakes decisions.
The growing importance of Integrated Delivery Networks (IDNs) and health systems exemplifies how the healthcare landscape is rapidly changing.
US payers reject 69% of prescriptions during the first year of FDA approval, highlighting the need for strategic payer engagement.